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Abstract: Background: Constipation is a common public health concern experienced by all individ-
uals during their life affecting the quality of life. In this paper, we aimed to provide an overview of 
the existing evidence regarding the role of food ingredients, including bran, prune, fig, kiwifruit, and 
flax-seed in constipation treatment. 
Scope and Approach: We searched Scopus, Pub Med, and Science Direct by using the keywords, 
“laxative foods” and “constipation”, for searching studies assessing laxative food ingredients and 
their beneficial effects on constipation treatment and/or control. 
Key Finding and Conclusion: Lifestyle modifications such as increasing dietary fiber and fluid in-
take and daily exercise are the proposed first line treatments for constipation. Optimizing ‘diet’ as an 
efficient lifestyle factor may contribute to the well-being of patients. The use of laxative food ingre-
dients including bran, prune, fig, kiwifruit, flax-seed, probiotics, and prebiotics is a convenient alter-
native to cope with constipation. According to previous findings, laxative food ingredients could be 
considered as effective treatments for subjects suffering from constipation. Many studies have as-
sessed the pharmacological and non-pharmacological roles of these ingredients in treating constipa-
tion, however, their importance has not been thoroughly investigated. 
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1. INTRODUCTION 
According to the ROME III criteria [1], constipation is 
diagnosed when at least 2 of the following items are includ-
ed: straining during defecation, lumpy or hard stools, a sen-
sation of incomplete evacuation or anorectal obstruction, 
manual maneuvers to facilitate defecation, and/or less than 
three defecations per week [2]. Generally, constipation is 
defined as the infrequent or difficult passage of stool and is 
the most prevalent functional gastrointestinal disorder [3]. 
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Constipation dramatically affects health-related quality of 
life due to a wide range of signs and symptoms including 
discomfort, restlessness, vomiting, abdominal distension, gut 
obstruction and perforation. An association between consti-
pation and fatal pulmonary embolism has also been reported 
[3-6]. Pulmonary embolization results from the performance 
of the Valsalva maneuver and its effects on peripheral blood 
flow and intrathoracic pressures, contributing to constipation 
[7]. The frequency rate of constipation is crucial. However, a 
prevalence of 50% has been reported among adults [8]. In 
the British population, the prevalence of constipation was 
reported between 2%-51.5% [9-12]. In Western societies, the 
prevalence of functional constipation among the elderly pop-
ulation was reported to be about 24%, which was more 
common among women [13]. Chronic functional constipa-
tion is affected by demographic characteristics (age and gen-
2     Current Nutrition & Food Science, 2019, Vol. 15, No. 0 Dargahi et al. 
der), physical activity, dietary habits, psychosocial and be-
havioral factors, and socioeconomic status [14] Additionally, 
it may be primary or secondary to other medical problems 
such as endocrine and metabolic disorders, myopathic, psy-
chological conditions and structural abnormalities of the 
intestinal tract. For instance, individuals with neurological 
disorders are at higher risk for constipation with a prevalence 
of 27-62% [15, 16]. 
Treatment of constipation still remains a clinical chal-
lenge. In a recent study on over 5000 patients receiving med-
ications for constipation, about 50% of them were dissatis-
fied with their current therapy [17]. On the other hand, only 
about one-third of constipated patients seek medical care and 
many of them self-treat their symptoms either by increasing 
their fiber intake or by using over-the-counter (OTC) laxa-
tives [2, 18]. Initial therapeutic measures in disease man-
agement include recommendations for modifying lifestyle 
such as adequate fluid intake and non-strenuous exercise, 
increasing natural fiber intake, and sparing time for bowel 
movements (BMs) [19]. However, evidence supporting these 
measures is rather weak [20]. There are several traditional 
therapeutic methods for constipation including bulking 
agents (psyllium), stool softeners (apricots, peaches, plums, 
grapes, prunes), stimulant laxatives (senna), osmotic laxa-
tives (foods high in fiber), etc. [21, 22]. However, it should 
be kept in mind that repeated administration of purgative 
medicines may result in diarrhea, enteritis, colorectal dys-
function, and may also be considered as a risk factor for col-
orectal neoplasm [23]. In mild functional constipation, gen-
eral treatment measures such as increased intake of water 
and dietary fiber, and the use of simple laxatives have been 
suggested. A diet with enough fiber (20-35 g each day) helps 
form a soft and bulky stool. Sufficient dietary fiber is also 
needed to promote normality in bowel movement frequency 
over the long term [24]. Colonic transit has been shown to be 
related to stool weight and dietary fiber intake [24]. Howev-
er, to the best of our knowledge, there are only few studies 
assessing dietary fiber intake by patients with chronic con-
stipation [24]. Thus, the present study was conducted with 
the aim of reviewing laxative food ingredients used for treat-
ing and/or controlling constipation. 
2. METHODS 
A comprehensive literature review was conducted with 
the use of the Scopus, PubMed, and Science Direct scientific 
databases, without the limit of the year of publication. Key 
search words included laxative food ingredients, bran, prune, 
fig, kiwifruit, flax-seed, probiotics, prebiotics, and constipa-
tion treatment. Published clinical studies were identified and 
reviewed for summarizing their findings in the present paper. 
The reference section of each identified publication was also 
searched for any studies that might have been missed in the 
database search. 
3. FINDINGS 
3.1. Classification of Constipation 
According to the pathophysiology of constipation, it can 
be divided into three groups: slow transit (ST), normal-
transit (NT) or obstructed defecation (OD) constipation. Paré 
et al. (2007) in a study on North American population re-
ported that 59%, 13%, and 25% of patients suffered from 
NT, ST and OD forms of constipation, respectively. Addi-
tionally, 3% of them had a mixed ST/OD condition [16]. 
Likewise, in a study on Thai population, the prevalence of 
NT, ST and OD conditions was reported to be 47%, 13%, 
29%, respectively, along with 11% with a mixed ST/OD 
condition [25]. However, this classification has some over-
laps and on the other hand, constipation may be associated 
with Irritable Bowel Syndrome (IBS). In general, there is 
about a 50% overlap between IBS and ST constipation. Fur-
thermore, it has been shown that 10% to 13% overlap exists 
between ST and OD forms of constipation [26]. 
3.1.1. Slow Transit Constipation  
There are some pieces of evidence on the possibility that 
ST constipation may be due to global motor abnormality. 
Abnormalities in the ST form of constipation are not limited 
to the colon and rectum but motility changes in the stomach 
and jejunum have also been documented. Scott et al. (2003) 
reported evidence of jejunal motility disorders in about one-
third of patients with the ST condition [27]. Delayed gastric 
emptying and abnormal gastric accommodation have also 
been reported by other authors [28-30]. A loss of coordina-
tion between contractile activity in the rectum and sigmoid 
colon as well as reduced rectal sensory threshold have been 
implicated in ST constipation [30-33]. In fact, ST constipa-
tion is more prevalent in young women who have less bowel 
movement [34]. In these patients, a high-fiber diet may in-
crease stool weight, decrease colon-transit time, and eventu-
ally relieve constipation. Patients with severe ST conditions 
show poor response to dietary fiber and laxatives [34-39].  
3.1.2. Normal-Transit Constipation  
Normal-Transit or functional constipation is the most 
prevalent form of constipation. In patients with this form of 
illness, stool transition and frequency are normal [40]. These 
patients feel difficulty in defecation or hard stools. Further-
more, patients may experience bloated and abdominal 
cramping and pain as well as psychological distress [40], and 
some of them may have reduced rectal sensation [41]. Die-
tary fiber alone or in combination with osmotic laxatives 
could relieve the symptoms of this type of constipation [39]. 
Failure to respond to these interventions suggests an im-
paired disturbance of evacuation or transit. However, this 
condition needs further management [42]. 
3.1.3. Obstructed Defecation 
This syndrome is relatively common, which is character-
ized by a difficult and often painful evacuation, a sense of 
incomplete evacuation, perineal support or finger insertion 
into the vagina or anus to defecate, frequent enemas, and 
laxative abuse. Half of the constipated patients suffer from 
OD, occurring more frequently in females (II). The patho-
physiology of OD is poorly understood. Recent studies have 
suggested that this syndrome develops because of multiple 
and/or difficult labors and is the cause of obstruction. It may 
result from rectoanal intussusception, rectocele, pelvic organ 
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prolapse, enterocele, sigmoidocele, or solitary rectal ulcer 
syndrome. Furthermore, rectal hyposensitivity (blunted rec-
tum), idiopathic megarectum, hereditary internal sphincter 
myopathy and nutcracker anus are the rare causes of OD [43, 
44]. Osmotic agents are useful for patients who suffer from 
OD and in whom first-line bulk-forming agents or stool sof-
teners do not work. Some recent evidence suggested that low 
dosage of polyethylene glycol (PEG), lactulose, and sorbitol 
as osmotic agents enhances stool passage in these patients 
[45, 46]. 
3.2. Defecation Disorders 
Defecation disorders are common due to the dysfunction 
of the pelvic floor or anal sphincter. Some other terms used 
to describe defecation disorders include anismus, pelvic-
floor dyssynergia, obstructed constipation and functional 
fecal retention in childhood [36]. Behavioral issues such as 
sexual abuse play an important role in this type of constipa-
tion [47], as well as conscious frequent suppression and 
postponement of the urge to defecate [37]. 
3.3. Pregnancy Constipation 
As mentioned before, constipation could be experienced 
at all periods of life such as childhood, adulthood or old age. 
Constipation is also a common problem among pregnant 
women. 
About 11-38% of pregnant women suffer from constipa-
tion, especially in the third trimester. Physiologic and ana-
tomic changes in the gastrointestinal tract predispose preg-
nant women to develop constipation. Continuously rising 
progesterone and estrogen concentration and reduction in the 
motilin hormone level have been suggested as the causes of 
constipation during pregnancy [48, 49]. Also, water absorp-
tion increases in the intestine, which causes the stool to dry 
out. Low fluid and fiber intake, decreased maternal activity, 
and increased vitamin supplementation (e.g, iron and calci-
um) may also be the contributing factors [48, 49]. 
3.4. Treatment of Constipation 
Chronic constipation is a hard-to-treat condition, thus 
prevention is considered as the best solution [50]. There is a 
wide range of treatment measures. Pharmacological (over-
the-counter) laxatives are the most common treatments for 
constipation. However, these drugs are not ideal for clinical 
practice due to their potential adverse side effects [51] and 
thus, patients should be informed of their side effects. There-
fore, alternative treatment measures are required. Although 
there is limited data on the effectiveness of lifestyle and be-
havioral modification, it could be considered as the recom-
mended first-line treatment [52]. Increasing fiber intake 
through dietary or medicinal intervention (laxative foods) 
has been well accepted as a method of choice in modality 
treatment in order to relieve symptoms, especially com-
plaints of infrequent or hard stools [51].  
3.4.1. Lifestyle and Dietary Modification 
The gentlest remedies for constipation include increased 
physical activities, certain yoga postures, an increase of fluid 
intake and dietary changes including increased fiber and fruit 
intake. The adequate intake (AI) values of 21 and 38 g/d 
were established for women and men 19 years or older [53]. 
It is well known that fibers have an important role in the oc-
currence and development of constipation, however, the total 
dietary fiber intake in adults appears to be much less than the 
AI levels [54]. Therefore, although some drugs and other 
modalities (e.g. biofeedback, surgery) have been used to treat 
constipation, intake of sufficient amount of dietary fibers is 
still a cornerstone in the prevention and treatment of this 
disorder [55].  
3.4.2. Pharmacological Treatments 
3.4.2.1. Bulking Laxatives 
These organic polysaccharides are effective in the treat-
ment of constipation via retaining fluid in the stool and in-
creasing stool weight and consistency [16, 18, 56, 57]. Ex-
amples of organic polysaccharides are bran, psyllium (natu-
ral agents), methylcellulose and calcium polycarbophil (syn-
thetic agents). Fiber has no major adverse effects and is usu-
ally well tolerated. However, flatulence, abdominal bloating, 
pain and stool impaction are reported as the side-effects of 
such treatments [58, 59]. 
3.4.2.2. Stool Softeners 
Stool softeners mainly act as detergents and lubricate 
stool by enhancing interaction between water and solid stool, 
thereby these agents lead to soft and consistent stool and 
ease evacuation of hard stool. This category involves docus-
ate sodium and docusate calcium. There is insufficient data 
to support their effectiveness on chronic constipation [58, 
60]. 
3.4.2.3. Osmotic Laxatives 
Lactulose, PEG, sorbitol, Magnesium hydroxide (milk of 
magnesia), and magnesium citrate have been considered as 
osmotic agents. Poorly absorbed ions or molecules draw 
water into the lumen and therefore cause softer stool and 
ease clone propulsion [61]. Abdominal cramping, bloating, 
and flatulence may be the side effects of these agents but 
seldom they lead to electrolyte imbalance [50]. In recent 
years, several new pharmacological classes have appeared or 
have been studied for the treatment of chronic constipation 
such as 5-HT4 receptor agonists, colonic secretagogues and 
opioid antagonists [62].  
3.4.2.4. HT4 Receptor Agonists 
Serotonin (5-hydroxytryptamine, 5-HT) regulates gastro-
intestinal motility and sensitivity and also secretion through 
the activation of the 5-HT receptor located in the gastrointes-
tinal enteric nervous system [62, 63]. Cisapride and Tegaser-
od are used in the treatment of constipation but these drugs 
increase the risk of cardiovascular events and subsequently 
have been withdrawn from the market [62]. Prucalopride, a 
full 5-HT4 receptor agonist from the benzofuran carbox-
amide chemical class (a), improves colonic transit in humans 
[64, 65]. The data of a majority of clinical trials do not indi-
cate any significant cardiovascular toxicities of Prucalopride 
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[66]. A number of other 5-HT4 agonists such as velusetrag 
(TD-5108) and naronapride (ATI-7505) are under considera-
tion. These drugs enhance transit time [67].  
3.4.2.5. Colonic Secretagogues 
Lubiprostone is one of the novel therapies identified as 
an effective agent in the management of chronic constipation 
by promoting the secretion of intestinal fluid, but few pa-
tients have claimed nausea during treatment [68, 69]. Anoth-
er new drug presented in the market is Linaclotide which 
acts as a luminal guanylin receptor and enhances intestinal 
chloride and fluid secretion [70].  
3.4.2.6. Opioid Antagonists 
In order to treat opiate-induced constipation, a number of 
opioid antagonists are recently being investigated. Since the-
se agents do not cross the blood-brain barrier, they have been 
used for reducing peripheral adverse effects of opioids such 
as constipation, nausea and vomiting without any interrup-
tion with analgesic efficacy. A meta-analysis assesses the 
efficacy of methylnaltrexone and alvimopan, while there is 
not enough evidence for other antagonists such as naloxone 
and nalbuphine [71]. However, the use of opioid antagonists 
in non-opiate-induced constipation treatment protocols has 
not been completely assessed [72].  
3.4.3. Laxative Foods 
As mentioned above, most patients do not consider the 
order of treatment according to the guidelines and immedi-
ately use OTC laxatives and other related medicines without 
trying natural laxatives present in food ingredients like fruit, 
dried fruit, seeds, etc. Since medications have shown some 
side effects and usually patients are not satisfied with their 
treatments, food-based, natural alternatives are needed to 
substitute the current on the market OTC laxatives and fiber 
supplements as the first line treatment. Several studies have 
been conducted to evaluate the effect of laxative food ingre-
dients on constipation treatment (Table 1). Some foods such 
as prunes, pears, figs, kiwifruit, bran cereals, flax-seed, and 
other fiber-rich agents produce bulky stool and help in fre-
quent intestinal movements and contractions and conse-
quently result in the prevention and treatment of constipation 
[15]. 
Table 1. Selected publications on Laxative food ingredients for constipation prevention and treatment. 
Food Ingredients Dose Period Health Condition Effect Ref. 
Wheat bran 10g 4 wk Elderly patients 
Improved stool weight and consistency and re-
duced the number of days without stools com-
pared with control phase 
[113] 
DisivitTM (mixed of 
oats, corn, wheat and 
soybean) 
12.5g dietary 
fiber 
2 wk Constipated patients 
Improved bowel movement frequency and stool 
consistency and reduced laxative intake com-
pared with basal phase 
[137] 
Wheat bran 21g 2 wk 
Patients with irritable bowel 
syndrome constipation 
Improved stool frequency, consistency and ab-
dominal pain compared with basal phase but 
abdominal distension increased 
[138] 
Bran 20g/d 4 wk 
Patients with chronic  
constipation 
Intestinal transit time decreased and bowel fre-
quency and stool weight increased in comparison 
to their two-week basal period 
[139] 
Bran 20g/d 4 day Orthopedic surgical patients 
Bowel movement increased and incidence of 
constipation reduced compared with control 
group 
[140] 
Wheat bran 40g 6 d Healthy volunteers 
Stool output, bowel movement frequency in-
creased, mean stool water content increased 
compared with placebo-controlled group 
[141] 
Wheat bran 20g 6 d Healthy volunteers 
Stool output, bowel movement frequency and 
mean stool water content increased compared 
with placebo-controlled group 
[141] 
Rye bread 
8 ×40 g fibre 
rich rye bread 
3 wk Free-living subjects 
Total intestinal transit time decreased, fecal 
frequency increased and gastrointestinal symp-
toms increased compared with subjects who 
intake yoghurt containing Lactobacillus or 
control group 
[142] 
(Table 1) contd… 
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Food Ingredients Dose Period Health Condition Effect Ref. 
Wheat bran+  
psyllium 
69g 3 wk Free-living participants 
Increases in fecal bulk, less intestinal transit 
time, greater bowel movement frequency, in-
crease in activity of the bowel compared with 
control diet 
[143] 
Rye bread 240 g/d 3 wk 
Adults with self-reported con-
stipation and using laxatives 
Total intestinal transit time reduced, the number 
of bowel movements increased, Feces was more 
frequently softened and defecation was eased 
compared with other groups 
[144] 
Dietary fiber (Glu-
comannan) 
100 mg/kg per 
d up to 5 g/d 
4 wk 
Chronically constipated  
children 
Defecation frequency and abdominal pain im-
proved 
[145] 
Cocoa husk supple-
ment (fiber) 
10.4 g/d (3-6 
y) or 20.8 g/d 
(7-10 y) 
4 wk 
Children with chronic  
idiopathic constipation 
Total transit time decreased, number of bowel 
movements increased, reports of hard stools 
reduced, stool consistency and pain improved 
[146] 
Dietary fiber 
10 g fiber in 
125-mL yogurt 
drink 
8 wk Children with constipation 
No difference in defecation frequency and fecal 
incontinence frequency compared with subjects 
who intake lactulose 
[147] 
Dietary fiber  
(Glucomannan) 
100 mg/kg two 
times a day 
12 wk 
Children with severe brain 
damage and chronic  
constipation 
Stool frequency increased, Laxative use and 
painful defecation was reduced in comparison to 
placebo group 
[148] 
Inulin enriched 
yogurt (1.23 g inulin 
in 100g yogurt) 
125 ml en-
riched yogurt 
twice a day 
2 wk 
IBS patients with constipation 
(IBS-C) 
Stool frequency increased, Bowel transit time 
decreased, emptying, Bloating and Abdominal 
pain improved compared with placebo group 
[149] 
Prunes 100 g 12 wk 
Healthy postmenopausal  
women 
No difference in bowl movement compared with 
subjects who intake 75 g of dried apples daily 
[74] 
prune juice 
125 mL of the 
test prune 
juice, twice a 
day 
2 wk 
Volunteers with certain  
gastrointestinal symptoms 
Difficulty of defecation decreased but flatulence 
increased compared with baseline 
[77] 
Yoghurt containing 
galacto-
oligosaccharides 
(GOS), prunes and 
linseed 
GOS (12 
g/day), prunes 
(12 g/day) and 
linseed (6 
g/day) 
3 wk 
Elderly subjects with self-
reported constipation 
Defecation frequency increased, defecation was 
easier, constipation relieved compared with 
baseline and control group 
[150] 
Prune 
at least 50 g of 
prune and 200 
ml of prune 
juice per day 
4 wk 
Adults with self-reported  
constipation 
Bowel movements increased, defecation time 
decreased, stool consistency increased, and ab-
dominal pain during defecation decreased com-
pared with placebo group 
[151] 
Prunes/psyllium 100 g/11g 3 wk 
Patients with chronic  
constipation 
Bowel movements and stool consistency in-
creased compared to psyllium 
[152] 
Kiwifruit 
One kiwifruit 
per 30 kg 
bodyweight 
3 wk Healthy volunteers 
Bulkier and softer stool, as well as more frequent 
stool production compared with baseline 
[104] 
Kiwifruit 
Kiwi fruit 
twice daily 
4 wk Constipated patients 
Transit time, rectal sensation and score for an-
noyance of constipation decreased and satisfac-
tion of bowel habit improved, decrease in days of 
laxative use compared with baseline 
[24] 
Kiwifruit 
Two Hayward 
green ki-
wifruits per 
day 
4 wk Patients diagnosed with IBS/C 
Colon transit time decreased, defecation frequen-
cy increased and bowel function improved com-
pared with control group 
[97] 
(Table 1) contd… 
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Food Ingredients Dose Period Health Condition Effect Ref. 
Fermented milk 
(containing probiot-
ics) 
2.6×108 CFU/g 11 d Healthy volunteers Improvement in colonic transit time [122] 
The Bifdus product 
(fermented milk 
containing yoghurt 
cultures plus probi-
otics) 
Between 5 
×107and 108 
CFU/g 
10 d Healthy female volunteers Colonic transit time decreased [153] 
Probiotic 109 CFU/g 12 wk Children with Constipation No effects [154] 
Capsules containing 
probiotic 
8 × 108 CFU/g 4 wk 
Children with chronic constipa-
tion 
Defecation frequency increased, Abdominal pain 
and hard stool decreased 
[13] 
Fermented milk 
containing probiotic 
plus yoghurt strains 
1.25 
× 1010 CFU/g 
 
2 wk Patients with constipation 
Stool frequency increased, defecation condition 
and stool consistency improved 
[155] 
Fermented milk 
containing probiotic 
with two classical 
yoghurt starters 
1.25 × 1010 
CFU/g 
4 wk 
Patient who fulfilled the Rome 
III criteria for IBS-C 
Abdominal girth and gastrointestinal transit 
improved and symptomatology reduced 
[156] 
Buttermilk contain-
ing probiotic 
2 × 1010 CFU/g 3 wk 
Adults with self-reported con-
stipation and using laxatives 
Not effective in relieving constipation [144] 
Commercially drops 
containing probiotic 
108 CFU/g 8 wk 
Infants diagnosed with func-
tional chronic constipation 
Frequency of bowel movements increased, no 
significant difference in stool consistency 
[157] 
Capsules containing 
probiotic 
17.2 × 109 
CFU/g 
2 wk 
Adults with self-reported  
constipation 
Reduction in frequency of functional gastrointes-
tinal symptoms in adults, decrease of Whole gut 
transit time 
[158] 
Capsules containing 
probiotic 
1.8 × 109 
CFU/g 
2 wk 
Adults with self-reported  
constipation 
Reduction in frequency of functional gastrointes-
tinal symptoms in adults, decrease of Whole gut 
transit time 
[158] 
Probiotic milk drink 6.5×109 CFU/g 4 wk 
Patients with chronic  
constipation 
Reduction of colonic transit time [159] 
Artichokes enriched 
with probiotics 
2 × 1010CFU/g 2 wk Constipated patients 
Satisfactory relief of symptoms, reduction in 
Gastrointestinal Symptom Rating Scale ques-
tionnaire and in its single items (frequency of 
evacuation, hard stools and feeling of incomplete 
evacuation) 
[160] 
Fermented milk 
containing probiotic 
3 × 1010 CFU/g 4 wk 
Subjects with functional  
constipation 
No deferences [161] 
Fermented milk 
drink containing 
probiotic 
6.5 × 109 
CFU/g 
8 wk 
Subjects suffering from hard 
stools 
Stool became softer, improvement of stool con-
sistency 
[162] 
Probiotic 108 CFU/g 4 wk 
Adult with functional  
constipation 
Improvement of bowel movement frequency, no 
effect on stool consistency 
[163] 
Protexin (composed 
of seven probiotic) 
109 CFU/g 4 wk 
Children with chronic  
constipation 
Improvement of stool frequency and consistency [164] 
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3.4.3.1. Plum (Prune) 
Garden plum (Prunus domestica) is being cultivated 
since the 12th century. It has different shapes, colors, sizes 
and fruit ripening date [73]. Plum has lower fat content and 
higher level of important nutrients including carbohydrates, 
vitamins and minerals and is considered as a healthy food. 
As a dietary component, plum has health-promoting features 
[74] and has an important role in clinical settings. The heal-
ing effects of plum have been observed in measles, and 
blood circulation and digestive problems [75]. Although 
dried plums and their juice are commonly used for constipa-
tion relief, other health benefits of them are less known 
among the general public [74]. Since it contains high con-
tents of sorbitol and chlorogenic acids, plum is considered as 
a contact laxative [76]. Piirainen et al. (2007) observed the 
mild laxative effects of daily administration of prune juice in 
human volunteers [77]. Because of its beneficial nutritive 
value and relatively high amounts of biologically-active 
compounds, plum should be considered as a fixed element in 
human diet, whether as fresh fruit, traditional jam or prunes 
[73]. In addition to high contents of soluble and insoluble 
dietary fibers (about 6 g fiber/100 g including hemicellulose 
(3.0 g), pectin (2.1 g) and cellulose (0.9 g)), dried prunes 
contain other components that may contribute to the gastro-
intestinal function. These components include sugar alcohol 
sorbitol (14.7 g/100 g) and phenolic compounds (184 
mg/100 g), predominantly chlorogenic and neochlorogenic 
acids, all of which are poorly absorbed by the small intestine 
and pass undigested into the colon [78]. Since sorbitol is not 
absorbed, in some healthy individuals it can act as an osmot-
ic agent [79] and provide laxative effects [80]. The colonic 
microbiota ferments soluble fibers such as pectin and results 
in the proliferation of bacterial populations, generation of 
SCFA (short-chain fatty acid), and increase in stool weight 
[81]. On the other hand, insoluble fibers such as cellulose 
through mechanical intra-luminal stimulation induce the se-
cretion and GI peristalsis resistant colonic fermentation and 
increase stool water and bulk [82]. In vitro studies demon-
strated that chlorogenic acid is metabolised by specific co-
lonic microbiota to form phenolic breakdown products such 
as caffeic acid, which stimulate bifidobacteria [83]. 
Bifidobacteria have been shown to have laxative effects 
when taken as a probiotic and after prebiotic supplementa-
tion [84].  
3.4.3.2. Fig 
Cultivated fig (Ficus carica L.) belongs to the Moraceae 
family and is considered as an important source of human 
food [85]. Figs contain cellulose, minerals, vitamins, and 
amino acids [86, 87] as well as high levels of fiber, minerals 
and water. Laxative activities of fig extract and paste have 
been reported previously. The cellulose content of fig via 
increasing water content and bulk and elevating viscosity 
could lead to an increase in fecal excretion [23]. Feeding fig 
paste increases fecal weight and reduces colonic transit time 
(CTT) in animals with diet-induced constipation [23]. It has 
been reported that oral administration of fig paste is safe and 
thus may be advised for constipated patients, especially those 
with diet-induced constipation [23]. 
3.4.3.3. Flax-seed 
Flax (Linum usitassimum), a member of the Linaceae 
family, is an annual herb with a crispy texture, nutty taste 
and blue flowers. Flax-seeds are small and flat and are found 
in various colors from golden yellow to reddish-brown [88, 
89]. They are also known as linseed. Although these terms 
are used interchangeably in the literature, the term flax-seed 
denotes comestible flax while linseed refers to its industrial 
applicant [88]. Stem yields are good quality fiber with high 
strength and durability. The dietary fiber content of flax-seed 
has raised growing interest among nutritionists and medical 
researchers [90]. Both soluble and insoluble dietary fibers 
are found in flax-seed. Flax helps reduce the risk of various 
disorders such as heart, blood, joints, colon, aging and brain 
diseases [91]. For centuries, flax-seed has been used as a 
traditional medicine for constipation treatment. As a rich 
source of dietary fiber, flax-seed improves IBS symptoms 
such as constipation, abdominal pain and diarrhea [91]. Ad-
ditionally, it softens the stool and increases its weight and 
size which results in easy passage of stool leading to de-
creased constipation and developing haemorrhoids. Although 
it has been indicated that flax-seed has similar laxative ac-
tions in both healthy [92, 93] and constipated individuals 
[55], few relevant controlled trials are available. For in-
stance, in an animal study, Xu et al. (2012) showed that the 
administration of PDFM resulted in significant increments in 
stool frequency and weight and a marked decrement in the 
start time of defecation in both normal and constipated mice 
[93]. Although soluble fibers have wide effects on gastroin-
testinal transit [93], it was shown that the insoluble ones that 
inhibit digestive processes of the intestine lead to a reduction 
in the transit time within the stomach and the small intestine 
[94]. Furthermore, because of their swelling property, insol-
uble fibers cause larger bulk in the intestines. In fact, the 
laxative effects of dietary fibers (mixtures of soluble to in-
soluble) from natural food sources are entirely dependent on 
the luminal bulk [94].  
3.4.3.4. Kiwifruit 
Actinidia deliciosa, a genus of plants mostly cultivated 
for its fruit (kiwifruit), grows in various countries especially 
in Italy, New Zealand, Chile, and France [95]. These coun-
tries produce kiwifruit in large quantities. In a recent review 
of the potential health benefits of kiwifruit, its ability to im-
prove gastrointestinal disorders, particularly constipation has 
been reported [96]. Because of its high dietary fiber capacity, 
as well as cysteine protease constituent and actinidin, a pro-
teolytic enzyme of thiol-proteases, kiwifruit has been con-
sidered to have laxative effects [97, 98]. Kiwifruit is sug-
gested to be a good dietary supplement, especially for the 
elderly who often experience constipation [98]. Kiwifruit is a 
good source of dietary fibers containing about 3.4 g /100 
dietary fiber, which has high water-holding capacity which 
facilitates fecal bulking and improves laxation. The most 
important dietary fiber constituents in kiwifruit, in order of 
quantity, are in the form of pectic galactins [99, 100], hemi-
celluloses and cellulose [101-103]. Furthermore, actinidin, a 
proteolytic enzyme belonging to the class of thiol-proteases, 
can stimulate receptors in the colon, which increases colonic 
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motility, and finally facilitates laxation. To date, laxative 
effects of kiwifruit such as softening stool and increasing 
fecal bulking have been suggested in numerous anecdotal 
reports [104, 105]. Furthermore, other studies have investi-
gated the ability of zyactinase (the 100% natural ingredient 
derived from kiwifruit) to decrease constipation [95]. How-
ever, no controlled human trial data is available. The effec-
tiveness of kiwifruit administration in constipated patients 
along with the improvement in their anorectal physiology 
has been reported [24, 98]. Additionally, Chan et al. (2010) 
indicated the treatment benefits of kiwifruit consumption 
only for 6 months or more in Chinese constipated subjects 
[97]. Furthermore, as a routine dietary constituent, kiwifruit 
appears to be an effective natural dietary intervention for 
IBS/C patients [97]. In constipated patients, consumption of 
kiwifruit resulted in significant decrements in CTT, im-
provements in stool form and volume, along with increased 
ease and satisfaction of defecation resulting in relief from 
constipation [98, 104, 105]. 
3.4.3.5. Bran 
Bran is the coarse outer layer of cereal grain, such as 
wheat, rye and corn [106]. Bran is one of the most effective 
ingredients in increasing fecal weight [107]. Wheat bran has 
the best laxative potential among other bran such as cereals, 
partly because it is more resistant to fermentation than rye or 
oat bran [108]. On the other hand, few studies suggested 
corn bran as the most effective one [109]. Regular consump-
tion of wheat bran decreases intestinal transit time [109, 
110]. Some studies suggested that it is generally quite effec-
tive in decreasing transit time and increasing stool weight in 
healthy people but not for treating chronic constipation 
[111]. Wheat bran has been advocated to control constipa-
tion, and studies on its laxative effects go far back to 1930s 
[112, 113]. It has been suggested that intestinal transit is 
pathologically slow in individuals in industrialized societies 
due to the consumption of fiber-depleted foods [91]. There-
fore, addition of low-cost bran to the diet has been suggested 
[114]. Currently it has been found that adding more wheat 
and bran fiber to the diet would be beneficial in alleviating 
pregnancy constipation via increasing the frequency of defe-
cation and is preferable to stimulant laxatives, which may 
have side effects [115]. The effect of wheat bran on transit 
time has been studied in healthy subjects and in in-patients 
with constipation and irritable-colon syndrome [114]. In 
general, these studies showed that the administration of bran 
decreased the transit time in subjects with initially long 
(about 3 days or more) transit time, whereas it was slower 
among subjects with shorter (1 day or less) transit time 
[114]. In addition, in these studies, treatment with bran was 
followed by increased fecal volume. In addition to wheat, 
fiber-rich cereals such as rye and oats have much higher fe-
cal-bulking potential than fruits and vegetables [116].  
3.4.3.6. Probiotic and Prebiotic Foods 
According to the Food and Agriculture Organiza-
tion/World Health Organization, probiotics are defined as 
“live microorganisms which when administered in adequate 
amounts confer health benefits on the host” [117, 118]. Pro-
biotics are reported to be useful in preventing a wide range 
of diseases as well as treating the existing symptoms [118, 
119]. Many foods are rich in probiotics, including yogurt, 
kefir, fermented foods, such as sauerkraut and kimchi, 
kombucha, traditional fermented buttermilk, and fermented 
cheeses, such as Gouda [120]. The intestine, its microbiota, 
and the associated immune system have been the principal 
targets for consuming probiotics [121]. Currently, probiotics 
are used as effective agents in treating constipation. Studies 
have shown that imbalance of gut microbiota may result in 
constipation. Some probiotics, including Bifidobacteria and 
lactobacilli, decline colon pH by producing lactic, acetic and 
other acids and cause increased peristalsis of the colon and 
subsequently decrease CTT [122, 123]. There are no reports 
on the serious side effects of probiotics especially bifidobac-
teria and lactobacilli and studies showed good toleration in 
adults and children [124]. The diversity of probiotic strains 
used in clinical trials has complicated interpretation [124].  
Prebiotics are non-digestible food ingredients that bene-
ficially affect the host by selectively stimulating the growth 
and/or activity of one or a limited number of bacteria in the 
colon and thus improve the health of the host [125]. The 
stimulated bacteria of beneficial nature include bifidobacte-
ria and lactobacilli [126]. The beneficial effects of prebiotics 
on constipation include enhancing biomass, stool weight, 
frequency and the health of the bowel mucosa [127]. In prac-
tice, prebiotics are non-digestible short-chain carbohydrates 
(SCCs) produced by human enzymes and sometimes catego-
rized as non-digestible oligosaccharides (NDOs)v [128]. 
Among these prebiotics, inulin and oligosaccharides are the 
most studied prebiotics and have been recognized as dietary 
fibers in most countries. Studies showed that inulin and oli-
gosaccharides could enhance stool frequency and weight 
[129-133]. Similar to other fermented carbohydrates, prebi-
otics have mild laxative effects. Due to the small magnitude 
of laxation, it is difficult to demonstrate in human studies 
[134]. They are found in many high-fiber foods, including 
some fruits, vegetables, and whole grains. Some probiotic-
rich foods may also contain prebiotics [135]. Human milk 
also has oligosaccharides that stimulate the growth of 
bifidobacteria in the infant's gut. Frequently occurring con-
stipation in non-prebiotic formula-fed infants may be related 
to the absence of this substance [136]. 
CONCLUSION 
Constipation is a common health problem affecting peo-
ple of all ages with undesirable effects on the quality of life. 
Most affected patients use over-the-counter laxatives which 
do not have side effects. It is logical to emphasize on life-
style modification before taking any medication. These mod-
ifications include diet and physical activity, especially 
choosing beneficial food. Food ingredients such as fruits 
(plum, fig, kiwifruit) and seeds (flax-seed) naturally contain 
laxative materials which could be useful for chronic consti-
pation by including them in the diet. All types of constipa-
tion may be successfully prevented and/or treated with laxa-
tive foods including wheat bran, prune, rye, inulin, kiwifruit, 
and pre/probiotic. Thus, it is suggested to use laxative foods 
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alone or in combination with each other to prevent or treat 
constipation.  
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